REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization

This is a real-world data study reviewing medical records of epilepsy patients who started a newer anti-seizure medication called cenobamate. The goal is to understand how this medication affects healthcare use (like hospital visits) in people whose seizures weren't controlled by previous drugs. **You may be eligible if...** - You are 18 or older - You have epilepsy with focal-onset seizures that were uncontrolled despite trying 2–5 previous anti-seizure medications - You started cenobamate treatment at a defined point in time - You had at least 1 seizure per month in the 6 months before starting cenobamate - Your medical records cover at least 6 months before and 12 months after starting treatment **You may NOT be eligible if...** - You have not had prior inadequate seizure control - Your medical records are incomplete for the required timeframes - You did not give consent for personal data processing Talk to your doctor to see if this trial is right for you.